Evidence map›Paper›PMID 40697179›Full record

ArticleActa oncologica (Stockholm, Sweden)2025

Outcome of lung cancer surgery and proportion of lung cancer patients eligible for surgery in five Finnish hospitals in 2018, real world study.

Ville Paappanen, Jenny Tikka, Arja Jukkola, Tuula Klaavuniemi, Liisa Sailas, Maria Tengström, Hanne Kuitunen, Teemu Riekkinen, Satu Tiainen, Outi Kuittinen

Abstract read
In one paragraph

Article in Acta oncologica (Stockholm, Sweden), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ville PaappanenFaculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Jenny TikkaFaculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. jennytik@student.uef.fi.ORCID 0009-0004-7913-4358
Arja JukkolaDepartment of Oncology, Tampere University Hospital, Tampere, Finland.
Tuula KlaavuniemiFaculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Liisa SailasDepartment of Oncology, Joensuu Central Hospital, Joensuu, Finland.
Maria TengströmFaculty of Health Medicine, Institute of Clinical Medicine University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.
Hanne KuitunenDepartment of Oncology, Oulu University Hospital, Oulu, Finland.
Teemu RiekkinenDepartment of Surgery, Kuopio University Hospital, Kuopio, Finland.
Satu TiainenFaculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland; FICAN East, the Wellbeing Services, county of North Savo, Kuopio, Finland.
Outi KuittinenFaculty of Health Medicine, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeLung cancer is one of the most common malignancies worldwide and is associated with high mortality. In Finland, overall lung cancer survival is lower than in other Nordic countries. A recent Finnish Cancer Registry publication reported that only 11.8% of patients underwent surgery. We aimed to assess whether operability and surgical outcomes contribute to Finland's inferior lung cancer survival rates. MATERIAL AND

methodsThis retrospective study analysed patient data of five Finnish hospital databases. We focused on potentially operable patients, specifically those with non-small cell lung cancer in stage I-IIIA according to computer tomography. A total of 156 patients met the staging criteria, of whom 77 underwent surgery. Among potentially operable patients, 50.6% were deemed ineligible for surgery due to various factors, including poor pulmonary or cardiac function, comorbidities, or localised tumour spread.

resultsIn our material 156 out of 545 were potentially operable and 77 were operated. 2-year overall survival for operated patients was 79%.

interpretationWe found that patients with lung cancer in Finland present with poorer overall health, a slightly more advanced stage distribution among potentially operable cases, and a lower overall rate of surgical treatment compared to other Nordic countries. Additionally, patients in Finland tend to undergo surgery at more advanced stages. These factors likely contribute to Finland's lower lung cancer survival rates. This study underscores that delayed diagnosis and a lower proportion of patients undergoing surgery may be key contributors to Finland's poorer treatment outcomes.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsPneumonectomyAdultAgedAged, 80 and overFemaleFinlandHumansMaleMiddle AgedNeoplasm StagingRegistriesRetrospective StudiesSurvival RateTreatment Outcome

Identifiers

PMID40697179
PMCPMC12305687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.